Literature DB >> 22072760

Conserved glycine 33 residue in flexible domain I of hepatitis C virus core protein is critical for virus infectivity.

Allan G N Angus1, Antoine Loquet, Séamus J Stack, David Dalrymple, Derek Gatherer, François Penin, Arvind H Patel.   

Abstract

Hepatitis C virus core protein forms the viral nucleocapsid and plays a critical role in the formation of infectious particles. In this study, we demonstrate that the highly conserved residue G33, located within domain 1 of the core protein, is important for the production of cell culture-infectious virus (HCVcc). Alanine substitution at this position in the JFH1 genome did not alter viral RNA replication but reduced infectivity by ∼2 logs. Virus production by this core mutant could be rescued by compensatory mutations located immediately upstream and downstream of the original G33A mutation. The examination of the helix-loop-helix motif observed in the core protein structure (residues 15 to 41; Protein Data Bank entry 1CWX) indicated that the residues G33 and F24 are in close contact with each other, and that the G33A mutation induces a steric clash with F24. Molecular simulations revealed that the compensatory mutations increase the helix-loop-helix flexibility, allowing rescue of the core active conformation required for efficient virus production. Taken together, these data highlight the plasticity of core domain 1 conformation and illustrate the relationship between its structural tolerance to mutations and virus infectivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072760      PMCID: PMC3255827          DOI: 10.1128/JVI.05452-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Structure and dynamics changes induced by 2,2,2-trifluoro-ethanol (TFE) on the N-terminal half of hepatitis C virus core protein.

Authors:  Jean-Baptiste Duvignaud; Denis Leclerc; Stéphane M Gagné
Journal:  Biochem Cell Biol       Date:  2010-04       Impact factor: 3.626

Review 2.  New therapies for hepatitis C virus infection.

Authors:  Vincent Soriano; Marion G Peters; Stefan Zeuzem
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

3.  Torsion angle dynamics: reduced variable conformational sampling enhances crystallographic structure refinement.

Authors:  L M Rice; A T Brünger
Journal:  Proteins       Date:  1994-08

4.  Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles.

Authors:  Pablo Gastaminza; Sharookh B Kapadia; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 5.  Assembly of infectious hepatitis C virus particles.

Authors:  Ralf Bartenschlager; Francois Penin; Volker Lohmann; Patrice André
Journal:  Trends Microbiol       Date:  2010-12-14       Impact factor: 17.079

Review 6.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

7.  Biosynthesis and biochemical properties of the hepatitis C virus core protein.

Authors:  E Santolini; G Migliaccio; N La Monica
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Sequence analysis of the core gene of 14 hepatitis C virus genotypes.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

9.  Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo.

Authors:  José M Cuevas; Fernando González-Candelas; Andrés Moya; Rafael Sanjuán
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

10.  Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7.

Authors:  Yasuyuki Fujimoto; Hiroyuki Itabe; Jun Sakai; Minoru Makita; Junich Noda; Masahiro Mori; Yusuke Higashi; Shinichi Kojima; Tatsuya Takano
Journal:  Biochim Biophys Acta       Date:  2004-02-02
View more
  10 in total

1.  Intrinsic disorder mediates hepatitis C virus core-host cell protein interactions.

Authors:  Patrick T Dolan; Andrew P Roth; Bin Xue; Ren Sun; A Keith Dunker; Vladimir N Uversky; Douglas J LaCount
Journal:  Protein Sci       Date:  2014-12-31       Impact factor: 6.725

2.  Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication.

Authors:  Andrea Magri; Alexander A Ozerov; Vera L Tunitskaya; Vladimir T Valuev-Elliston; Ahmed Wahid; Mario Pirisi; Peter Simmonds; Alexander V Ivanov; Mikhail S Novikov; Arvind H Patel
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

3.  17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle.

Authors:  Andrea Magri; Matteo N Barbaglia; Chiara Z Foglia; Elisa Boccato; Michela E Burlone; Sarah Cole; Paola Giarda; Elena Grossini; Arvind H Patel; Rosalba Minisini; Mario Pirisi
Journal:  Liver Int       Date:  2016-11-25       Impact factor: 5.828

4.  The role of PTEN - HCV core interaction in hepatitis C virus replication.

Authors:  Qi Wu; Zhubing Li; Paul Mellor; Yan Zhou; Deborah H Anderson; Qiang Liu
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

5.  Anti-Hepatitis C Virus Activity of Uridine Derivatives of 2-Deoxy Sugars.

Authors:  Ewelina Krol; Ilona Wandzik; Gabriela Pastuch-Gawolek; Boguslaw Szewczyk
Journal:  Molecules       Date:  2018-06-27       Impact factor: 4.411

6.  HCV Activates Somatic L1 Retrotransposition-A Potential Hepatocarcinogenesis Pathway.

Authors:  Praveen D Sudhindar; Daniel Wainwright; Santu Saha; Rachel Howarth; Misti McCain; Yvonne Bury; Sweta S Saha; Stuart McPherson; Helen Reeves; Arvind H Patel; Geoffrey J Faulkner; John Lunec; Ruchi Shukla
Journal:  Cancers (Basel)       Date:  2021-10-11       Impact factor: 6.639

7.  A Metabolomics Profiling Study in Hand-Foot-and-Mouth Disease and Modulated Pathways of Clinical Intervention Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry.

Authors:  Cheng Lu; Xinru Liu; Xiaorong Ding; Xiao Chen; Haiwei Fan; Yunqiang Liu; Ning Xie; Yong Tan; Joshua Ko; Weidong Zhang; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-19       Impact factor: 2.629

8.  HCV core residues critical for infectivity are also involved in core-NS5A complex formation.

Authors:  Katarzyna Gawlik; James Baugh; Udayan Chatterji; Precious J Lim; Michael D Bobardt; Philippe A Gallay
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

9.  Coevolution analysis of Hepatitis C virus genome to identify the structural and functional dependency network of viral proteins.

Authors:  Raphaël Champeimont; Elodie Laine; Shuang-Wei Hu; Francois Penin; Alessandra Carbone
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

10.  Novel Uridine Glycoconjugates, Derivatives of 4-Aminophenyl 1-Thioglycosides, as Potential Antiviral Compounds.

Authors:  Ewelina Krol; Gabriela Pastuch-Gawolek; Binay Chaubey; Gabriela Brzuska; Karol Erfurt; Boguslaw Szewczyk
Journal:  Molecules       Date:  2018-06-13       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.